ArticleDrug design, development and therapy2025

Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of rhIL-7-hyFc, a Hybrid Fc-Fused Long-Acting Interleukin-7, to Support Optimal Dosing Regimens in Patients with Solid Cancer.

Seohyeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.